FORBEARANCE AGREEMENTForbearance Agreement • July 23rd, 2020 • Nugenerex Immuno-Oncology, Inc. • Pharmaceutical preparations • Maryland
This FORBEARANCE AGREEMENT (this "Agreement"), effective as of the last date of signature below (hereinafter the "Effective Date"), is entered into by and among Antigen Express, Inc. ("Antigen Express") and Generex Biotechnology Corporation ("Generex," and together with Antigen Express the "Companies") and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (the "Foundation"). The Companies and Foundation sometimes are referred to collectively as the "Parties" or individually as a "Party."
